Discovery & Innovation

We recently talked about how Green Fluorescent Protein, restriction enzymes, and CRISPR are invaluable products of basic research. These...

Over the course of the last century we’ve had the age of antibiotics, the genetic revolution, transplantation and immunotherapy, each of which...

Whenever it is announced that budgets must be tightened, it is often scientists performing basic research who are among the first to be called to...

The increasing awareness of the scientific research community on the importance of open access and openscience has given rise to a new funding...

While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of...

Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug...

Last year, Scientist announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases. We know how...

We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug...

If you hobnob around scientists, you might be increasingly hearing the mysterious acronym “CRISPR” being mentioned in conversation. CRISPR...

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...